上周五早上,中心Disease Control and Protection (CDC) Director Rochelle P. Walensky, MD, MPH, endorsed the CDC Advisory Committee on Immunization Practices (ACIP) recommendation for a booster shot of the Pfizer-BioNTech COVID-19 vaccine in certain populations plus expanded on ACIP’s advice by recommending a booster dose for those in high risk occupational and institutional settings.
The Food and Drug Administration’s (FDA) authorization andCDC’s subsequent guidancefor use make it possible for eligible people to receive a booster dose immediately. It will allow millions of Americans who are at highest risk from COVID-19 to help increase their protection.
This guidance applies only to individuals who have already received the first two doses of the Pfizer-BioNTech vaccine. It does not apply to those who received the Moderna or Johnson & Johnson vaccines. Vaccine providers are advised to follow federal guidance when administering COVID-19 vaccines.
CDC recommends:
- People 65 years and older and residents in long-term care settingsshouldreceive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series.
- People aged 50–64 years withunderlying medical conditionsshouldreceive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series.
- People aged 18–49 years withunderlying medical conditionsmayreceive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks.
- People aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because ofoccupational or institutional settingmayreceive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks.
The College will keep you up to date on ongoing developments regarding COVID-19 vaccines.
